EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Postural Orthostatic Tachycardia Syndrome (POTS)

Tae Hwan Chung, Satish R Raj

JAMA · 06.10.2026 · 336 (13) · 1149

DOI: 10.1001/jama.2026.14809 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JAMA, erschienen am 06.10.2026. Verfasst von Tae Hwan Chung und 1 weiteren Autor:innen. Beteiligte Einrichtung: Shirley Ryan AbilityLab, Chicago, Illinois. Hauptthemen laut MEDLINE: Postural Orthostatic Tachycardia Syndrome, Autonomic Nervous System. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 103 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Postural orthostatic tachycardia syndrome (POTS) is a chronic autonomic disorder characterized by excessive orthostatic tachycardia and multisystem symptoms that affects an estimated 0.1% to 1% of the US population. POTS can substantially impair daily functioning and quality of life. Observations Consensus criteria define POTS by chronic symptoms of orthostatic intolerance accompanied by a sustained heart rate increase of at least 30 beats/min (≥40 beats/min in adolescents aged 12-19 years) within 10 minutes of standing or head-up tilt from a supine position in the absence of orthostatic hypotension, defined as a decrease in either systolic blood pressure of at least 20 mm Hg or diastolic blood pressure of at least 10 mm Hg with positional change. POTS symptoms may include palpitations, lightheadedness, nausea, vomiting, gastroparesis, anorexia, generalized weakness, and muscle pain, despite absence of structural pathology within cardiovascular, gastrointestinal, and neurological organs. POTS predominantly affects females (approximately 90% of cases), with peak incidence from ages 13 to 29 years. However, the true prevalence remains uncertain partly due to underrecognition and lack of a specific diagnostic code for POTS until 2022. Common symptoms include lightheadedness, palpitations, fatigue, cognitive dysfunction (“brain fog”), exercise intolerance, nausea, bloating, constipation, diarrhea, and sleep disturbance. In a survey of 4835 patients, approximately 70% reported substantial functional impairment and loss of school or work participation, and median diagnostic delay was 24 months. In 30% to 40% of cases, symptoms began within 3 months after infections, such as SARS-CoV-2, Epstein-Barr virus, and influenza. Initial evaluation should exclude other conditions that cause sinus tachycardia, including thyroid disease, adrenal insufficiency, pheochromocytoma, cardiomyopathy, valvular heart disease, congenital heart disease, chronic lung disease, medication effects (eg, stimulants, norepinephrine reuptake inhibitors, and diuretics), anemia, and dehydration. First-line treatment includes nonpharmacological strategies to improve cardiac preload, including increased fluid and sodium intake, lower-body compression garments; avoidance of heat exposure, dehydration, and prolonged standing; and structured supervised aerobic training. Pharmacological therapies should be individualized and may include β-blockers, ivabradine, midodrine, fludrocortisone, and pyridostigmine, although evidence supporting many therapeutic interventions is limited by small studies and lack of large, randomized trials. Conclusions and Relevance POTS is a chronic autonomic disorder associated with functional impairment and reduced quality of life that is diagnosed based on characteristic orthostatic symptoms in the absence of orthostatic hypotension after excluding alternative causes of sinus tachycardia. Treatment involves nonpharmacological measures (such as increased fluid and sodium intake), lower-body compression garments, structured exercise training, and individualized pharmacological therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Postural Orthostatic Tachycardia SyndromeAutonomic Nervous SystemAdolescentChildFemaleHumansMaleYoung AdultPrevalenceQuality of LifeHeart RateTilt-Table TestAdultMiddle AgedIncidenceExercise

Autor:innen und Institutionen

  • Shirley Ryan AbilityLab, Chicago, Illinois.
  • Department of Physical Medicine and Rehabilitation, Northwestern University, Chicago, Illinois.
  • Department of Physical Medicine and Rehabilitation, Johns Hopkins University, Baltimore, Maryland.
  • Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada.
  • Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Zitieren

APA

Chung, T. H., & Raj, S. R. (2026). Postural Orthostatic Tachycardia Syndrome (POTS). JAMA, 336(13), 1149. https://doi.org/10.1001/jama.2026.14809

Vancouver

Chung TH, Raj SR. Postural Orthostatic Tachycardia Syndrome (POTS). JAMA. 2026;336(13):1149. doi:10.1001/jama.2026.14809

BibTeX
@article{Chung2026,
  author = {Chung, Tae Hwan and Raj, Satish R},
  title = {Postural Orthostatic Tachycardia Syndrome (POTS)},
  journal = {JAMA},
  year = {2026},
  volume = {336},
  number = {13},
  pages = {1149},
  doi = {10.1001/jama.2026.14809}
}
Kostenlos starten →